MD
Mazzo David J
Chairman & CEO
C-suiteM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Mazzo David J, Chairman & CEO. Insider active across 2 companies, notably Caladrius Biosciences, INC.. Cumulatively, 13 filings have been published. Activity tracked since 10 January 2022. The latest transaction was filed on 9 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Mazzo David J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
81,000 shares0Common StockSEC:0001334549-26-000003:0
81,000 shares0Common StockSEC:0001334549-25-000002:0
58,000 shares@ US$2.9395.5% of flowCommon StockSEC:0001334549-24-000006:0
1,026 shares@ US$2.991.7% of flowCommon StockSEC:0001334549-24-000004:0
94,000 shares0Common StockSEC:0001334549-24-000002:0
397 shares@ US$3.650.8% of flowCommon StockSEC:0001334549-23-000006:0
1,030 shares@ US$3.201.9% of flowCommon StockSEC:0001334549-23-000004:0
60,000 shares0Common StockSEC:0001334549-23-000002:0
150,000 shares@ US$0.5089.2% of flowCommon StockSEC:0001334549-22-000007:0
6,471 shares@ US$0.806350.0% of flowCommon StockSEC:0001334549-22-000004:0
401,000 shares0Common StockSEC:0001334549-22-000002:0
212,800 sharesCommon StockSEC:0001144204-16-077388:0
21,094 sharesCommon StockSEC:0001144204-16-077388:1
About Mazzo David J
David J. Mazzo is the Chief Executive Officer of Caladrius Biosciences, Inc. He leads the company with a strategic vision, overseeing operations and growth initiatives. With significant experience in the biopharmaceutical sector, Mazzo is responsible for the strategic direction of Caladrius.